Mr. Speaker, my fellow Canadians and I know that our neighbours to the south have begun vaccinating all at-risk individuals with FluMist, a nasal aerosol produced by AstraZeneca.
Can the minister explain why this company, which also operates in Canada, is still waiting for the government to give the green light for production of this vaccine? If not, can she tell me why my granddaughter who lives in the United States can be protected, but not my granddaughter who lives in Canada?